Submissions from 2023
A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799933 (ARRY-440) as a single agent and in combination therapy in participants 16 years and older with advanced solid tumors with BRAF alterations, JTT Black, MH Taylor, and See all authors in comments
Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041), Bruno Bockorny, Steven O'Day, Kim Margolin, Rachel E Sanborn, Timothy S Kristedja, and See all authors in comments
If the Fates Allow: The Zero-Sum Game of ISCHEMIA-EXTEND., Steven M Bradley and Tyler J Gluckman
Improving patient outcomes through an evidence-based practice nursing boot camp, Kevin Brandini
Improving patient outcomes through an evidence-based practice nursing boot camp (program evaluation), Kevin Brandini
Results from an expanded phase 1 trial of botensilimab, a multifunctional anti-CTLA-4, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer, AJ Bullock, RE Sanborn, and See all authors in comments
MINI INTENSIVE: APP: Creating a Sustainable and Achievable Culture Independence Salons F-H, Denise K. Busman, Tyler J Gluckman, and See full list of authors in comments
Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, CJ Calfa, WJ Urba, and See all authors in comments
Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab, Matteo S. Carlino, Matthew H. Taylor, and See all authors in comments
CT275 / 15 - Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors, B Carneiro, Rachel E Sanborn, and See full list of authors in comments
Advance Care Planning and End-of-Life Education in Heart Failure: Insights From the NCDR PINNACLE Registry., Casey E Cavanagh, Lindsey Rosman, Philip Chui, Karl Minges, Nihar R Desai, Sarah Goodlin, Savitri Fedson, John A Spertus, Tyler J Gluckman, Yang Song, Luke Zheng, Alexander Turchin, Gheorghe Doros, Jane J Lee, and Matthew M Burg
Direct Oral Anticoagulants and Warfarin Safety in Rural Patients with Obesity., Zachary R Caverley, Ross J Bindler, Pamela Soh, and Sherri Mendelson
Spontaneous coronary artery dissection: An underrecognized cause of ACS., Zachary R Caverley and Lori Tam
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial., Eric X Chen, Jonathan M Loree, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudharry E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C Wei, Dongsheng Tu, and Chris J O'Callaghan
HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer, D Chism, Brendan Curti, and See all authors in comments
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial., Byoung Chul Cho, Dong-Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura, Sang-We Kim, Rachel E Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna Minchom, Jong-Seok Lee, Ji-Youn Han, Misako Nagasaka, Joshua K Sabari, Sai-Hong Ignatius Ou, Patricia Lorenzini, Joshua M Bauml, Joshua C Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E Knoblauch, and Keunchil Park
Sexual and Gender Diversity in Pediatric Neurology: Why We Care., Alison Christy, Jaclyn Martindale, Jennifer Hranilovich, Casey Orozco-Poore, Finley Kernan-Schloss, Chase T M Anderson, Jonathan Strober, Wendy Mitchell, and Mackenzie P Lerario
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments., Michael D Chuong, Mary Ann Clark, Lauren E Henke, Amar U Kishan, Lorraine Portelance, Parag J Parikh, Michael F Bassetti, Himanshu Nagar, Stephen A Rosenberg, Minesh P Mehta, Tamer Refaat, Justin M Rineer, Adam Smith, Steven Seung, Bassem I Zaki, Martin Fuss, and Raymond H Mak
Associations between feeding and development in preterm infants in the NICU and throughout the first year of life., Ashleigh Connell, Kati Knudsen, Horia Marginean, and Michele Raddish
Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma, MA Couey, Matthew H Taylor, William L. Redmond, Brady Bernard, Richard Bryan Bell, Carlo Bifulco, Brian D. Piening, Walter Urba, Bernard A Fox, and Rom Leidner
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas., Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Thomas F Gajewski, Martin Gutierrez, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Elisabeth I Heath, John A Thompson, Sahar Ansari, Celine Jacquemont, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, and Juneko E Grilley-Olson
Interdisciplinary Involvement in HTN Management, Kirsten Curcio, Maurice N. Tran, and Estera Ianciuc
Order Set Usage is Associated With Lower Hospital Mortality in Patients With Sepsis., chris dale, Shelley Schoepflin Sanders, Shu-Ching Chang, Omar Pandhair, Naomi G Diggs, Whitney Woodruff, David N Selander, Nicholas M Mark, Sarah Nurse, Mark David Sullivan, Liga Mezaraups, and D Shane O'Mahony
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial., Michael I D'Angelica, Ryan J Ellis, Jason B Liu, Brian C Brajcich, Mithat Gönen, Vanessa M Thompson, Mark E Cohen, Susan K Seo, Emily C Zabor, Michele L Babicky, David J Bentrem, Stephen W Behrman, Kimberly A Bertens, Scott A Celinski, Carlos H F Chan, Mary Dillhoff, Matthew E B Dixon, Carlos Fernandez-Del Castillo, Sepideh Gholami, Michael G House, Paul J Karanicolas, Harish Lavu, Shishir K Maithel, John C McAuliffe, Mark J Ott, Bradley N Reames, Dominic E Sanford, Umut Sarpel, Courtney L Scaife, Pablo E Serrano, Travis Smith, Rebecca A Snyder, Mark S Talamonti, Sharon M Weber, Adam C Yopp, Henry A Pitt, and Clifford Y Ko
Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas., Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, and David G Kirsch
Assessing Competencies and Giving Feedback, CH Davies
What About Other Non-Invasive (Non-Pharmacologic) Therapies for Refractory Angina?, CH Davies
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care., Jaydira Del Rivero, Josh Mailman, Michael W Rabow, Jennifer A Chan, Sarah Creed, Hagen F Kennecke, Janice Pasieka, Jennifer Zuar, Simron Singh, and Lauren Fishbein
Frailty is Not Associated with Worse Outcomes following Lower Extremity Angiograms for Limb Ischemia in Nonagenarians., Jaclyn DeRieux, Dina Obed, Arianne Johnson, Michael Paisley, Michelle Wang, and Kevin M Casey
Longitudinal Policy and Systems Change as a Component of Community Power., Claire Devine, Ritu Ghosal, Maggie Weller, Taylor Doren, Chia Hua Yu, Roxanne Marsillo, and Natalie Royal Kenton
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results., Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V Long, Paolo A Ascierto, James Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbe, Gaëlle Quéreux, Friedegund Meier, Brendan Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, and Nikhil I Khushalani
Participation in genetic screening: testing different outreach methods across a diverse hospital system based patient population., Lindsay Dickey, Benjamin Gronowski, Kyle Jones, J B Rinaldi, Kate Emery, Jon Clemens, Ora K Gordon, and Keri B Vartanian
Immunotherapy for brain metastases and primary brain tumors., Anna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, Andrea Anichini, Ramy Ibrahim, Michael Weller, Michael Lahn, Alexander M M Eggermont, Bernard Fox, and Michele Maio
ASHP Foundation Pharmacy Forecast 2023: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems., Joseph T DiPiro, Todd W Nesbit, Charles Reuland, Francesca E Cunningham, Pamela Schweitzer, Marie A Chisholm-Burns, Leyner Martinez, Rita Shane, Christopher M Scott, Scott D Nelson, Dara L E Mize, Elva Van Devender, and Lance Oyen
MDR1-EXPRESSING CD4, Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, and Christine Ménétrier-Caux
Exploring the frequency of hospital-based chaplain and nursing interactions, Sheila Doucette
Co-Designing an Initiative to Increase Shared Access to Older Adults' Patient Portals: Stakeholder Engagement., Vadim Dukhanin, Jennifer L Wolff, Liz Salmi, Kendall Harcourt, Deborah Wachenheim, Ira Byock, Matthew J Gonzales, Doug Niehus, Marianne Parshley, Caroline Reay, Sara Epstein, Supriya Mohile, Timothy W Farrell, Mark A Supiano, Anushka Jajodia, Catherine M DesRoches, and Shared Access Project Team
Functional Outcomes in Patients with Large Vessel Occlusion Anterior Circulation Strokes Presenting with Low NIHSS Score with or without Thrombectomy Treatment, M Duncan, Alyx Lesko, and See all authors in comments
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study., Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, and Richard L Schilsky
Registry Data Show Complication Rates and Cost in Revision Hip Arthroplasty., Paul J Duwelius, Richard D Southgate, James P Crutcher, Genevieve M Rollier, Hsin-Fang Li, Katie S Sypher, and Geoffrey S Tompkins
Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC., Joseph E Ebinger, Tyler J Gluckman, Jose Magraner, Shih-Ting Chiu, Deanna Rider, Chelsey Thomas, Sandeep R Das, P Michael Ho, Satya Shreenivas, and Steven Bradley
Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)., Anthony B. El-Khoueiry, K A Margolin, Rachel E Sanborn, and See all authors in comments
Chapter: High-sensitivity C-reactive protein, DI Feldman, RS Blumenthal, and Tyler J Gluckman
NKG2A expression on tumor reactive CD8 T cells is induced by IL-12, O Fesneau, J Huang, T Duhen, and See full list of authors in comments
Immune Interception of Pre-Malignancy, B Fox
Cancer Vaccines, Bernard Fox
Cancer Vaccine Strategies, Bernard Fox
Cellular Therapy, Bernard Fox
Developing Combination Immunotherapy that Includes Cancer Vaccines, Bernard Fox
Developing Combination Immunotherapy with Cancer Vaccines, Bernard Fox
Developing Combination Immunotherapy with Cancer Vaccines, Bernard Fox
Immunotherapy of Cancer, Bernard Fox
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies., Bernard A Fox, Walter J Urba, Shawn M Jensen, David B Page, Brendan D Curti, Rachel E Sanborn, and Rom S Leidner
Relationships Between Perceived Importance of Chaplain Presence and Health Professionals' Emotional Well-Being in the United States., Adam Gaines, Teresa Rangel, Rachel Freedberg, Sheila Doucette, Danell Stengem, Rosemary Timmerman, Jamie Roney, Patrick Arenivar, Angela Patterson, JoAnn Long, Sarah Sumner, Dawn Bock, Sherri Mendelson, Trisha Saul, AnneMarie West, Robert E Leavitt, and Karen Colorafi
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study, Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis., A Reshad Garan, Rachna Kataria, Borui Li, Shashank Sinha, Manreet K Kanwar, Jaime Hernandez-Montfort, Song Li, VAN-Khue Ton, Vanessa Blumer, E Wilson Grandin, Neil Harwani, Peter Zazzali, Karol D Walec, Gavin Hickey, Jacob Abraham, Claudius Mahr, Sandeep Nathan, Esther Vorovich, Maya Guglin, Shelley Hall, Wissam Khalife, Paavni Sangal, Yijing Zhang, Ju H Kim, Andrew Schwartzman, Alec Vishnevsky, Daniel Burkhoff, and Navin K Kapur
Retrospective comparison of traditional and artificial intelligence-based heart failure phenotyping in a US health system to enable real-world evidence., Arthur Reshad Garan, Keri L Monda, Ricardo E Dent-Acosta, Daniel J Riskin, and Tyler J Gluckman
Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies, B Garmezy, Brendan Curti, and See full list of authors in comments
13. Long-term efficacy, safety and predictors of response to amivantamab among patients with post-platinum EGFR exon 20 insert (Ex20ins)-mutated advanced non-small cell lung cancer (aNSCLC) — CHRYSALIS (NCT02609776), P Garrido, Rachel E Sanborn, and See full list of authors in comments
Benzodiazepine-minimizing protocol for alcohol withdrawal: a comparative analysis, Jennifer Gaston, Hsin-Fang Li, Emily J Cox, Caitlin Klamper, and John F Wurzel
Precise tumor & patient selection for CDR404: A bispecific & bivalent MAGE-A4 T cell engager, G Giacomazzi, Rom Leidner, and See full list of authors in comments
Safety and Outcomes of Outpatient Pleural Drainage in Symptomatic Postoperative Cardiac Surgery Patients., Christopher R Gilbert, Austin M Meggyesy, Adam J Bograd, Shih Ting Chiu, Candice L. Wilshire, and Jed A Gorden
Mammogram perceptions, communication, and gaps in care among individuals with non-English language preference in Oregon and Washington states., Monique Gill, Hannah Cohen-Cline, Megan Holtorf, and Keri Vartanian
Bias-Based Bullying in California Schools: The Impact of the 2016 Election Cycle., Monique Gill and Diana Govier
Investing in community power building to increase civic engagement through voting: lessons from the Building Healthy Communities initiative, Monique Gill, Benjamin Gronowski, Elliott Moon, Claire Devine, Megan Holtorf, and Bill J. Wright
Risk factors for venous thromboembolism (VTE) among patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) receiving amivantamab plus lazertinib versus either agent alone, N Girard, Rachel Sanborn, and See all authors in comments
Coding Pearls for the Cardiovascular Service Line, Ty J. Gluckman (Moderator), Linda Gates-Striby, and Nicole Knight
Bring’em out to the clinic - Con virtual visits, Quality of Care and Outcomes Research (QCOR) Sessions, Tyler Gluckman
CV Health System Opening Discussion: Rapid Insights, Tyler Gluckman
Frontiers of Cardiovascular Risk Assessment: Moderator of Digital Poster Session, Tyler Gluckman
Hot takes: Contemporary discussions in cardiac care, Quality of Care and Outcomes Research (QCOR) Sessions, Tyler Gluckman
JACC Patient Care Pathways: VA-ECMO Use After Recent Autologous Stem Cell Transplant with Pancytopenia, Tyler Gluckman
Long COVID and the Heart, Tyler Gluckman
Target: Aortic Stenosis--Advancing a new standard of care in structural heart disease, Tyler Gluckman
The Persistent Pandemic: Impact of Long Hauler Cardiovascular Related Outcomes, Tyler Gluckman
Trends and Factors Associated with Prophylactic Anticoagulation Strategies in COVID-19: an Analysis of the AHA COVID-19 CVD Registry, Tyler Gluckman
Relationship between left ventricular ejection fraction and ICD-10 codes among patients hospitalized with heart failure, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
Temporal shift in heart failure diagnoses among hospitalized patients within a large US integrated health system, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
Temporal Shifts In Guideline-directed Medical Therapy Prescribed At Discharge To Heart Failure Patients In A Large US Integrated Health System, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
Cardiovascular Sequelae of COVID-19, Tyler J Gluckman
Temporal Shifts In Guideline-directed Medical Therapy Prescribed At Discharge To Heart Failure Patients In A Large US Integrated Health System, Tyler J Gluckman, Shih-Ting Chiu, Deanna Rider, Phil Tseng, James O Mudd, Joshua Remick, Slaven Sikirica, Amy Carroll, Craig Granowitz, Mario Enrico Canonico, Judith Hsia, and Marc Bonaca
Temporal shift in heart failure diagnoses among hospitalized patients within a large US integrated health system, Tyler J Gluckman, Shih-Ting Chiu, Deanna Rider, P Tseng, James O Mudd, Joshua Remick, M Canonico, and M Bonaca
363 Billion Reasons to Care: Reversing the Risking Tide of Cardiovascular Events, Tyler Gluckman and H Page
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock., Kashish Goel, Pinak Shah, Brandon M Jones, Ethan Korngold, Anju Bhardwaj, Biswajit Kar, Colin Barker, Molly Szerlip, Richard Smalling, and Abhijeet Dhoble
Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection., Josh Gottlieb, Shu-Ching Chang, Jane Choe, Gary Grunkemeier, Douglas Hanes, David L Krasne, Dave S B Hoon, and Timothy G Wilson
Predictors of Intraoperative Difficulty and Postoperative Examination Abnormalities in 164 Orbital Operations., Akshay Govind, Shaban Demirel, Kristin Lee, Melissa Amundson, Richard Bryan Bell, and Eric Dierks
Temporal shift in heart failure medications prescribed to hospitalized patients with and without diabetes in a large US integrated health system, C Granowitz, ST Chiu, J Remick, Tyler Gluckman, and See full list of authors in comments
Concordance between laboratory- and ICD-10 code-defined stages of chronic kidney disease among patients hospitalized with heart failure in a large US integrated health system, C Granowitz, HF Li, ST Chiu, J Remick, Tyler Gluckman, and See full list of authors in comments
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing., Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger, Robert L Diaz, Hallie A Swan, Danielle Peretti, Maddy Pollastro, Trevor Ainge, Katannya Kapeli, Shalini Pereira, Astrid L Margossian, Kalyan Banda, Barbara A Goff, Elizabeth M Swisher, Brady Bernard, Christopher J Kemp, and Carla Grandori
